Hinova Pharma Funding: $219M Raised, Series C (2020)
Hinova Pharma is based in Chengdu, China. It has raised $219M in total funding. Latest round: Series C.
Hinova Pharma funding overview
Hinova Pharma is based in Chengdu, China. Hinova Pharma has raised $219M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in October 2020. The round record for Hinova Pharma runs through 2020; nothing later has been disclosed. Investors on record include Shenzhen Investment Holdings, Hangzhou Tigermed, Sinopharm Group, DNV Capital, Huarong Rongde, Infinity Group and 1 others. 7 distinct backers are named across the disclosed rounds.
Hinova Pharma has raised $219M in total disclosed funding across the rounds on record.
Who has invested in Hinova Pharma?
Shenzhen Investment Holdings, Hangzhou Tigermed, Sinopharm Group, DNV Capital, Huarong Rongde, Infinity Group are named among the investors backing Hinova Pharma.
What was the latest Hinova Pharma funding round?
The most recent disclosed round is a Series C, announced in October 2020.
Where is Hinova Pharma based?
Hinova Pharma is based in Chengdu, China.
When did Hinova Pharma last raise?
The last disclosed Hinova Pharma round closed in October 2020 at Series C.
Hinova Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chengdu below to benchmark round size and investor mix.
